[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523228":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":108,"collaborators":11,"id":112,"slug":11,"hasResults":113,"nctId":114,"briefTitle":115,"officialTitle":116,"acronym":11,"eligibilityCriteria":117,"healthyVolunteers":113,"sex":118,"minAge":119,"maxAge":11,"enrollmentInfo":120,"targetDuration":11,"studyType":123,"phases":124,"briefSummary":126,"conditions":127,"keywords":134,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":147},{"fullName":5,"class":6},"Cedars-Sinai Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Arm","EXPERIMENTAL",null,[13,14],"Procedure: Breast Surgery (BCS or mastectomy) with TAD\u002FSNB","Radiation: Adjuvant Radiation Therapy",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"PROCEDURE","Breast Surgery (BCS or mastectomy) with TAD\u002FSNB","Breast surgery (BCS or mastectomy) with TAD\u002FSNB \\& Adjuvant Radiation therapy",[9],{"type":22,"name":23,"description":19,"armGroupLabels":24,"otherNames":11},"RADIATION","Adjuvant Radiation Therapy",[9],[26],{"name":27,"affiliation":5,"role":28},"Alice Chung, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Clinical Trial Navigator","CONTACT","3104232133","GroupCancerTrialInformation@cshs.org",[36,75,93],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute","RECRUITING","Los Angeles","California","90048","United States",{"type":44,"coordinates":45},"Point",[46,47],-118.24368,34.05223,{"lat":47,"lon":46},[50,53,56,58,60,62,63,65,67,69,71,73],{"name":51,"role":32,"phone":52,"phoneExt":11,"email":34},"Clinical Trial Recruitment Navigator","310-423-3713",{"name":54,"role":55,"phone":11,"phoneExt":11,"email":11},"Scott Karlan, MD","SUB_INVESTIGATOR",{"name":57,"role":55,"phone":11,"phoneExt":11,"email":11},"Armando Giuliano, MD",{"name":59,"role":55,"phone":11,"phoneExt":11,"email":11},"Catherine Dang, MD",{"name":61,"role":55,"phone":11,"phoneExt":11,"email":11},"Farin Amersi, MD",{"name":27,"role":28,"phone":11,"phoneExt":11,"email":11},{"name":64,"role":55,"phone":11,"phoneExt":11,"email":11},"Marissa Boyle, MD",{"name":66,"role":55,"phone":11,"phoneExt":11,"email":11},"Kjirsten Carlson, MD",{"name":68,"role":55,"phone":11,"phoneExt":11,"email":11},"Stephen Shiao, MD PhD",{"name":70,"role":55,"phone":11,"phoneExt":11,"email":11},"Julie Jang, MD",{"name":72,"role":55,"phone":11,"phoneExt":11,"email":11},"Michele Burnison, MD",{"name":74,"role":55,"phone":11,"phoneExt":11,"email":11},"Amin Mirhadi, MD",{"facility":76,"status":38,"city":77,"state":40,"zip":78,"country":42,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"CS Cancer at Huntington Cancer Center","Pasadena","91105",{"type":44,"coordinates":80},[81,82],-118.14452,34.14778,{"lat":82,"lon":81},[85,87,89,91],{"name":11,"role":32,"phone":86,"phoneExt":11,"email":11},"424-314-0177",{"name":88,"role":55,"phone":11,"phoneExt":11,"email":11},"Jeannie Shen, MD",{"name":90,"role":55,"phone":11,"phoneExt":11,"email":11},"Amy Polverini, MD",{"name":92,"role":55,"phone":11,"phoneExt":11,"email":11},"Alicia Terando, MD",{"facility":94,"status":38,"city":95,"state":40,"zip":96,"country":42,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"CS Cancer at Valley Oncology Medical Group","Tarzana","91356",{"type":44,"coordinates":98},[99,100],-118.55397,34.17334,{"lat":100,"lon":99},[103,106],{"name":104,"role":32,"phone":11,"phoneExt":11,"email":105},"Vanessa Vasco","Vanessa.Vasco@cshs.org",{"name":107,"role":55,"phone":11,"phoneExt":11,"email":11},"Lauren DeStefano, MD",{"type":109,"investigatorFullName":110,"investigatorTitle":111,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Alice Chung","Sponsor-Investigator","100523228",false,"NCT06092892","IIT2023-09-Chung-UpfrontTAD: Upfront TAD\u002FSNB in Patients With Breast Cancer With Nodal Metastases","IIT2023-09-Chung-UpfrontTAD: Upfront TAD\u002FSNB in Patients With Clinical T1-2N0 ER+ Her2- Breast Cancer With Ultrasound Detected Nodal Metastases","Inclusion Criteria:\n\n* Women age ≥ 45\n* Clinical T1-2N0 ER+ invasive breast cancer\n* US detected biopsy proven axillary nodal disease\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\n\nExclusion Criteria:\n\n* Palpable nodes on physical exam\n* Her2+ or ER- invasive breast cancer\n* Extranodal extension \\> 3 mm on nodal biopsy\n* More than 2 suspicious nodes on preoperative imaging","FEMALE","45 Years",{"count":121,"type":122},45,"ESTIMATED","INTERVENTIONAL",[125],"PHASE2","The purpose of the study is to determine the recurrence rates and survival of patients with clinical T1-2N0 ER+\u002FHer2- invasive breast cancer who have biopsy proven image detected nodal disease treated with upfront lumpectomy or mastectomy with TAD followed by adjuvant therapy. This is a prospective, single arm phase II clinical trial. Patients will be screened and enrolled per eligibility criteria. Patient, tumor, and treatment data will be documented.",[128,129,130,131,132,133],"Breast Cancer","Axillary Nodal Disease","Female Breast Cancer","Axilla; Breast","Mastectomy; Lymphedema","Tumor, Breast",[135,136,137],"T1-2N0 ER+ invasive","biopsy","upfront lumpectomy","2026-05-06",{"date":140,"type":141},"2026-05-11","ACTUAL",{"date":143,"type":141},"2024-04-07",{"date":145,"type":122},"2031-04",{"name":110,"class":6},3]